Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?

BACKGROUND: C reactive protein (CRP) levels are suggested as serum biomarkers in the diagnosis and prognosis of psoriatic arthritis (PsA). However, increased CRP levels are found in less than 50% of PsA patients even in the presence of active disease. OBJECTIVES: To evaluate the role of CRP levels i...

Descripción completa

Detalles Bibliográficos
Autores principales: Houttekiet, Charlotte, de Vlam, Kurt, Neerinckx, Barbara, Lories, Rik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830278/
https://www.ncbi.nlm.nih.gov/pubmed/35135860
http://dx.doi.org/10.1136/rmdopen-2021-001756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830278/
https://www.ncbi.nlm.nih.gov/pubmed/35135860
http://dx.doi.org/10.1136/rmdopen-2021-001756

Ejemplares similares